Holen Sie sich die Stockscreener-App
819.51
0.16%
-0.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push - WTVB
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide - Drug Topics
Jim Cramer on Eli Lilly Stock “Needs Some Kind of Catalyst to Get Things Going” - Yahoo! Finance UK
Lilly aligns with Walmart in bid to broaden access to discounted Zepbound - BioPharma Dive
Lilly, Walmart launch discount retail option for weight-loss drug Zepbound - Reuters
Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing - WSOC TV
Eli Lilly to Invest $1.2 Billion in Puerto Rico Plant Expansion - MarketScreener
Eli Lilly (LLY) Pours $1.2 Billion into Puerto Rico Expansion - GuruFocus
Eli Lilly to invest $1.2B in Puerto Rico plant - breakingthenews.net
Walmart and Eli Lilly to Offer In-Store Pickup for Zepbound With Direct-to-Consumer Pricing - PYMNTS.com
Lilly expands Zepbound direct-to-patient access through Walmart partnership - Indianapolis Business Journal
Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound - Pharmaceutical Commerce
Eli Lilly announces over $1.2B investment in Puerto Rico faciliy - TipRanks
Eli Lilly invests $1.2 billion to expand Puerto Rico manufacturing site - StreetInsider
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States - MarketScreener
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree? - The Globe and Mail
Eli Lilly (LLY) and Walmart Partner to Expand Access to Zepbound - GuruFocus
Eli Lilly, Walmart bring retail pick-up option with DTC pricing for Zepbound (WMT:NYSE) - Seeking Alpha
Eli Lilly strikes deal with Walmart to distribute cash-pay Zepbound vials - Sherwood News
Lilly, Walmart launch first retail pick-up option for weight-loss drug - Yahoo! Finance Canada
Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug - Stocktwits
Why Eli Lilly and Company stock is a strong buy callJuly 2025 Spike Watch & Accurate Trade Setup Notifications - Fundação Cultural do Pará
Top News Today: Lilly-NVIDIA AI Drug Discovery Deal, Sequoia’s $950M Fund Launch - Analytics Insight
Eli Lilly and Nvidia team up to build an AI supercomputer dedicated to drug discovery - MarketScreener
Eli Lilly partners with Nvidia to build AI supercomputer for drug discovery | Mint - Mint
Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential - NAI500
Lilly partners with Nvidia on AI supercomputer to speed up drug development - The Hindu
Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Lilly, Nvidia team up to build pharma’s ‘most powerful’ supercomputer - Indianapolis Business Journal
How Omvoh’s FDA Approval at Eli Lilly (LLY) Has Changed Its Investment Story - Yahoo Finance
1 Undervalued Growth Stock Down 8% to Buy Before 2026 - The Motley Fool
Eli Lilly and Company unveils Milan-Cortina athlete roster - Sports Business Journal
Eli Lilly (LLY) Partners with Nvidia for AI-Driven Drug Discover - GuruFocus
Lilly says it’s building pharma’s most powerful AI supercomputer with Nvidia - R&D World
Eli Lilly, J&J working with Nvidia to boost AI capabilities (LLY:NYSE) - Seeking Alpha
Eli Lilly and Company Partners with Nvidia to Build the Most Powerful Ai Supercomputer, Supercharging Medicine Discovery and Delivery for Patients - MarketScreener
Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer - statnews.com
Eli Lilly And Nvidia Build A Supercomputer For Drug Discovery - Finimize
NVIDIA (NVDA.US) partners with Eli Lilly and Co (LLY.US) to develop an AI-powered supercomputer for pharmaceutical applications. - 富途牛牛
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients - Investing News Network
Lilly keeps up legal fight against GLP-1 compounders - Endpoints News
Eli Lilly partners with Nvidia to build pharma’s most powerful AI supercomputer - TradingView
Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma - Fierce Biotech
Nvidia, Eli Lilly to build supercomputer for AI drug factory - breakingthenews.net
Eli Lilly is stockpiling its weight loss pill, plus Nvidia reveals (many) new partners - CNBC
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development - CNBC
Eli Lilly, Nvidia say they'll build pharma's largest supercomputer - Endpoints News
More than a third of Lilly's new Zepbound prescriptions are coming from DTC program - Endpoints News
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings - CNBC
Why Eli Lilly and Company stock remains on buy listsQuarterly Risk Review & Growth Focused Investment Plans - Fundação Cultural do Pará
Eli Lilly (LLY) Prepares for Major Launch of New Weight-Loss Pil - GuruFocus
Eli Lilly readies billions of weight-loss pills ahead of U.S. approval (LLY:NYSE) - Seeking Alpha
FDA OKs Once-Monthly Omvoh Injection Could Be a Game Changer for Eli Lilly (LLY) - simplywall.st
Lilly Makes Billions of Weight-Loss Pills Before US Approval - Bloomberg.com
Eli Lilly Manufactures Billions of New Weight-Loss Pill Ahead of US Approval - MarketScreener
Eli Lilly teams up with basketball legend Shaquille O'Neal to take sleep apnea awareness campaign to new heights - Fierce Pharma
With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big (NYSE:LLY) - Seeking Alpha
Eli Lilly Taps Eyecare Market With Definitive Agreement to Acquire Adverum Biotechnologies - VisionMonday.com
Will Eli Lilly and Company stock maintain momentum in 2025Market Weekly Review & Expert Approved Momentum Ideas - Fundação Cultural do Pará
Eli Lilly’s New Study on Pirtobrutinib: A Long-Term Safety Evaluation - TipRanks
Seeking Clues to Lilly (LLY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - sharewise.com
Eli Lilly (LLY) Gains FDA Approval for Monthly Ulcerative Colitis Treatment - GuruFocus
Eli Lilly’s New Study on LY3537031: What Investors Need to Know - TipRanks
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):